Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivone Gomes

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Modulation of opioid receptor function by protein-protein interactionsKonstantinos Alfaras-Melainis, Ivone Gomes, Raphael Rozenfeld, et al.
The Mount Sinai Journal of Medicine, New York|August 6, 2010
Role of antibodies in developing drugs that target G-protein-coupled receptor dimersChris Hipser, Ittai Bushlin, Achla Gupta, et al.
British Journal of Pharmacology|April 5, 2021
Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effectsMariana Rae, Mariana Lemos Duarte, Ivone Gomes, et al.
Biochemical Pharmacology|October 10, 2025
Antidepressants and the endogenous opioid systemLloyd D Fricker, Aya Osman, Achla Gupta, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2019
Opioid-Induced Signaling and Antinociception Are Modulated by the Recently Deorphanized Receptor, GPR171Max V McDermott, Leela Afrose, Ivone Gomes, et al.
Molecular Pharmacology|August 26, 2024
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid ReceptorsIvone Gomes, Achla Gupta, Elyssa B Margolis, et al.
Elife|April 28, 2021
Compartment-specific opioid receptor signaling is selectively modulated by different dynorphin peptidesJennifer M Kunselman, Achla Gupta, Ivone Gomes, et al.
Molecular Pharmacology|March 19, 2011
G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand bindingIvone Gomes, Adriaan P Ijzerman, Kai Ye, et al.
Molecular Pharmacology|October 24, 2018
Regulation of an Opioid Receptor Chaperone Protein, RTP4, by MorphineWakako Fujita, Mini Yokote, Ivone Gomes, et al.
Biochemical Pharmacology|September 28, 2014
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromersWakako Fujita, Ivone Gomes, Leonard S Dove, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Modulation of opioid receptor function by protein-protein interactionsKonstantinos Alfaras-Melainis, Ivone Gomes, Raphael Rozenfeld, et al.
The Mount Sinai Journal of Medicine, New York|August 6, 2010
Role of antibodies in developing drugs that target G-protein-coupled receptor dimersChris Hipser, Ittai Bushlin, Achla Gupta, et al.
British Journal of Pharmacology|April 5, 2021
Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effectsMariana Rae, Mariana Lemos Duarte, Ivone Gomes, et al.
Biochemical Pharmacology|October 10, 2025
Antidepressants and the endogenous opioid systemLloyd D Fricker, Aya Osman, Achla Gupta, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2019
Opioid-Induced Signaling and Antinociception Are Modulated by the Recently Deorphanized Receptor, GPR171Max V McDermott, Leela Afrose, Ivone Gomes, et al.
Molecular Pharmacology|August 26, 2024
Ketamine and Major Ketamine Metabolites Function as Allosteric Modulators of Opioid ReceptorsIvone Gomes, Achla Gupta, Elyssa B Margolis, et al.
Elife|April 28, 2021
Compartment-specific opioid receptor signaling is selectively modulated by different dynorphin peptidesJennifer M Kunselman, Achla Gupta, Ivone Gomes, et al.
Molecular Pharmacology|March 19, 2011
G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand bindingIvone Gomes, Adriaan P Ijzerman, Kai Ye, et al.
Molecular Pharmacology|October 24, 2018
Regulation of an Opioid Receptor Chaperone Protein, RTP4, by MorphineWakako Fujita, Mini Yokote, Ivone Gomes, et al.
Biochemical Pharmacology|September 28, 2014
Molecular characterization of eluxadoline as a potential ligand targeting mu-delta opioid receptor heteromersWakako Fujita, Ivone Gomes, Leonard S Dove, et al.
Pageof 8